title: [Antidepressants and cardiac side effects. Evaluation trial].
abstract: When a new antidepressant is put on the market, everyone is afraid of its possible cardiac effect. The control of unicellular potentials can give an hint about that effect, without being able to assess its severity; the 27 antidepressants commercialized in France have been reviewed. 180 cases of conduction delays from 10,060 overdosage in the Paris poison center were found, 7 times more often than with other drugs. In addition the 30 centers for monitoring of side effects of drugs have collected 38 cardiac side effects, as well arrhythmias or conduction disturbances.
authors.affiliation: Centre de Pharmacovigilance, Hôpital F. Widal, Paris.
authors.forename: M L
authors.initials: ML
authors.lastname: Efthymiou
authors.forename: A
authors.initials: A
authors.lastname: Castot
mesh_terms: D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D000928:Antidepressive Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000494:pharmacology; D004341:Drug Evaluation; D062787:Drug Overdose; D006321:Heart / Q000503:physiopathology; D006331:Heart Diseases / Q000139:chemically induced* / Q000503:physiopathology
chemical_list: D000928:Antidepressive Agents
vernacular_title: Antidépresseurs et effets indésirables cardiaques. Essai d'évaluation.